Stay updated on Nivolumab Combination in Stage III Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combination in Stage III Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combination in Stage III Melanoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Record History now includes revision v3.3.4 and the v3.3.3 entry has been removed.
    Difference
    0.1%
    Check dated 2026-01-14T01:36:16.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added to the Record History; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the page.
    Difference
    0.2%
    Check dated 2025-12-23T09:54:01.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Added revision entry v3.3.2 and removed revision v3.3.1 in the Record History.
    Difference
    0.1%
    Check dated 2025-12-01T17:44:05.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision history updated: added v3.3.1 and removed v3.2.0 from the Study Record Versions list on the Record History page.
    Difference
    0.1%
    Check dated 2025-11-24T14:53:11.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The change removes a general government funding/operating status notice that was displayed on the page; the core study record history remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2025-11-17T07:12:40.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Record History shows successive updates to core trial data, including study status, recruitment status, and study design, affecting how the trial's progression is viewed.
    Difference
    0.1%
    Check dated 2025-11-03T01:22:46.000Z thumbnail image

Stay in the know with updates to Nivolumab Combination in Stage III Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combination in Stage III Melanoma Clinical Trial page.